Mechanisms of Adverse Effects of Long-Acting Beta-Agonists in Asthma

NCT04503460 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Asthma

Interventions

DRUG: Salmeterol Xinafoate
DRUG: Salmeterol Fluticasone

Sponsor

Imperial College London

Collaborators

[object Object]